Osteoarthritis Therapeutics Market Share

Regionally, the osteoarthritis therapeutics market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. North America industry is expected to dominate majority revenue share by 2037, on the back of the presence of ultra-modern healthcare infrastructure in the region. According to the data released by the Centers for Diseases Control and Prevention, osteoarthritis affects over 32.5 million US adults. On the back of rising cases of osteoarthritis in the USA, patients are looking for effective measures of relief. This is estimated to propel the market growth during the forecast period.

The market is also projected to grow outstandingly during the forecast period in the Asia Pacific region. The region is highly populous and has a large number of osteoarthritis patients. The data released by the National Institute of Health and Family Welfare (NIHFW) in 2017, osteoarthritis is the 2^nd most common rheumatologic problem in India, and 70% of the people above 65 years show radiological evidence of osteoarthritis. Owing to this, the market growth is predicted to propel during the forecast period.